European panel recommends Amgen, Glaxo bone drug

… the biotech bone drug in Europe, throwing its marketing weight behind a product that analysts expect to make billions of dollars in annual sales. …

See all stories on this topic





This entry was written by Dean and Hillary Cram, posted on December 18, 2009 at 8:43 am, and filed under no sales news.

Post a Comment

Your email is never shared. Required fields are marked *

*
*